DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Sandborn WJ. et al.
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn’s disease.
Am J Gastroenterol 2004; 99: 1984-1989
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.